Business Context and Reporting Period
Company: CorMedix Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 27, 2020
Reporting Period: Event date November 27, 2020
CorMedix Inc. entered into an Amended and Restated At Market Issuance Sales Agreement to facilitate the sale of its common stock.
Key Financial Metrics
This filing is a current report regarding a corporate event and does not contain audited financial statements, revenue, profit, cash flow, or margin data.
- Proposed Capital Raise: Up to $25,000,000 in common stock.
- Commission Rate: 3% of the gross sales price per share paid to sales agents.
- Sales Agents: B. Riley Securities, Inc. and Needham & Company, LLC.
- Debt and Liquidity: The filing text does not provide a clear value for current debt levels or liquidity positions.
Material Changes
The material change reported is the execution of a new sales agreement allowing for "at the market" offerings of up to $25 million in equity. This replaces or amends prior arrangements for selling shares through these agents.
Guidance, Outlook, and Risks
Management Commentary: The Company intends to sell shares from time to time through the designated sales agents pursuant to its shelf Registration Statement on Form S-3 (Reg. No. 333-249901). A prospectus supplement was filed effective November 27, 2020.
Risks and Contingencies:
- Sales are subject to market conditions and the discretion of the Company.
- The issuance of shares may result in dilution to existing shareholders.
- The Company has provided customary indemnification and contribution rights to the sales agents.
Unusual Items: None reported in this filing.
Investor Verification Checklist
- Verify the current share price and potential dilution impact of a $25 million issuance.
- Review the full text of the Sales Agreement (Exhibit 1.1) for termination rights and specific selling restrictions.
- Check the Company's latest 10-Q or 10-K for current cash balances to assess the necessity of this capital raise.
- Confirm the status of the Form S-3 shelf registration (Reg. No. 333-249901).